2 -1 (51) 2023 — Tillyashaykhov M.N., Lipartia M.G. — STUDY OF IMMUNOHISTOMORPHOLOGICAL MARKERS AS CRITERIA FOR DIFFERENTIAL DIAGNOSIS OF Non-HODGKIN’S LYMPHOMAS (NHL) IN PEDIATRIC ONCOLOGY PRACTICE

STUDY OF IMMUNOHISTOMORPHOLOGICAL MARKERS AS CRITERIA FOR DIFFERENTIAL DIAGNOSIS OF Non-HODGKIN’S LYMPHOMAS (NHL) IN PEDIATRIC ONCOLOGY PRACTICE

Tillyashaykhov M.N., Republican Specialized Scientific-Practical Medical Center Of Oncology And Radiology MoH RUz

Lipartia M.G., Republican Specialized Scientific-Practical Medical Center Of Oncology And Radiology MoH RUz Tashkent pediatric medical institute

Alimov T.R. Scientific-research institute of Hematology and blood transfusion MoH RUz

Resume

The purpose of the study was to analyze the immunohystomorphological differentiation and results of non-Hodgkin’s lymphoma (NHL) in children in the population of Uzbekistan. The object of our research was statistician data, results of HistoloMorphologycal and ImmunoрHystoChemical (IHC) studies on all cases of NHL in children aged 2-17 years in the Republic of Uzbekistan. Studies show that the histological diagnosis of patients with diffuse B-cell lymphoma is centroblastic – 57.5%, immunoblastic – 6.0%, and T-histiocytic – 9.0%. % The immunocytomorphological features of NL in bollards of the population of Uzbekistan were determined, for which a high proliferative activity and B-cell lymphoma without T-cell markers was histologically characterized.

Keywords: non-Hodgkin lymphoma (NHL), diagnostics, immunohistochemical (IHC).

First page

7

Last page

11

For citation: Tillyashaykhov M.N., Lipartia M.G., Alimov T.R. – STUDY OF IMMUNOHISTOMORPHOLOGICAL MARKERS AS CRITERIA FOR DIFFERENTIAL DIAGNOSIS OF Non-HODGKIN’S LYMPHOMAS (NHL) IN PEDIATRIC ONCOLOGY PRACTICE //New Day in Medicien 1(51)2023 7-11 https://clck.ru/33JhdB

LIST OF REFERENCES:

1. Валиев Т.Т., Морозова О.В., Ковригина А.М., Махонова Л.А., Шолохова Е.Н., Серебрякова И.Н., Попа А.В., Тупицын Н.Н., Менткевич Г.Л. Диагностика и лечение анапластических крупноклеточных лимфом у детей //Гематология и трансфузиология. 2012. №1. – С. 3-9.
2. Глузман Д.Ф., Скляренко Л.М., Иванивская Т.С., Коваль С.В., Украинская Н.И., Полищук А.С., Швыдка М.С., Завелевич М.П. Новое в классификации ВОЗ В-клеточных опухолей лимфоидной ткани (пересмотр 2016 г.) //Онкологія. — 2017. — Т. 19. – № 1. — С. 80-85.
3. Коржевский Д.Э., Кирик О.В., Петрова Е.С., Карпенко М.Н., Григорьев И.П., Сухорукова Е.Г., Колос Е.А., Гиляров А.В. Теоретические основы и практическое применение методов иммуногистохимии. – //Litres, 2014. – С. 1-250.
4. Мелешко А.Н., Вашкевич Е.П., Дубровский А.Ч., Сачивко Н.В., Петровская Н.А. Иммунофенотипический анализ экспрессии поверхностного иммуноглобулина для уточнения морфологической диагностики В-клеточных лимфом //Онкологический журнал, Т.9, N1 (33), 2015  C. 21-28.
5. Armitage J.O. et al. Non-Hodgkin Lymphomas //2nd ed., Philadelphia, USA, 2010.  — P. 1-597.
6. Davies A., Cummin T.E, Barrans S., Maishman T.,  Mamot C., Novak U., Caddy J., Stanton L., Kazmi-Stokes Sh., McMillan A., Fields P., Pocock C., Collins G.P, Stephens R., Cucco F., Clipson A., Sha C. Tooze R., M.A Care, Griffiths G., Du M.-Q., Westhead D.R, Burton C., Johnson P.W.M.  Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial //Lancet Oncology, The, 2019-05-01, Том 20, Вып. 5, – С. 649-662. 
7. Herrera A. F., Molina A. Investigational Antibody–Drug Conjugates for Treatment of B-lineage Malignancies //Clinical Lymphoma, Myeloma & Leukemia, 2018-07-01, – 18(7). – P. 452-468.
8. Piña-Oviedo S., Moran C.A. Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 1. //Adv Anat Pathol. 2019 Nov; 26(6). – P. 346-370.